Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000898430-02-002149
Filing Date
2002-05-22
Accepted
2002-05-22 16:51:25
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3.txt S-3 195909
3 OPINION OF LATHAM & WATKINS dex51.txt EX-5.1 5645
4 OPINION OF SHEARMAN & STERLING dex81.txt EX-8.1 4140
5 STATEMENT REGARDING COMPUTATION dex121.txt EX-12.1 2464
6 CONSENT OF ERNST & YOUNG LLP dex231.txt EX-23.1 915
7 CONSENT OF ERNST & YOUNG LLP (IMMUNEX CORPORATION) dex232.txt EX-23.2 950
8 STATEMENT OF ELIGIBILITY QUALIFICATION FORM T-1 dex251.txt EX-25.1 25641
  Complete submission text file 0000898430-02-002149.txt   238026
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-88834 | Film No.: 02660092
SIC: 2836 Biological Products, (No Diagnostic Substances)